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ABSTRACT 
 
Medicinal plants are native legacies with universal and global significance that are considered as one of the most 
valuable assets of each country. To gain knowledge of these plants is one of the most important indicators of 
development in any countries. Study of medicinal plants in any region is very important for different potentials of 
these plants such as pharmacologic and industrial aspects. Regarding recent interest in and lack of information on 
medicinal plants, their therapeutic properties, and the approaches to their preparation and extraction, native 
information and traditional knowledge could contribute significantly to initiating scientific investigations on these 
plants. Therefore, it is necessary to take significant measures to use and promote systematic methods of utilization 
of these valuable resources by knowing these plants and obtaining necessary information about their habitats, 
ecological characteristics, and therapeutic uses. In this article, the latest scientific information on Allium 
hirtifolium, a medicinal, industrial and edible plant, is presented. 
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INTRODUCTION 
 
Human beings have long found that their lives, as with other animals, depend on the surrounding phenomena, 
especially on the growth of plants. They found that they could use plants and medicinal products for treatment of 
diseases and resulting complications. This requirement forced them to gain knowledge of medicinal plants and learn 
how to use them so that they could differentiate between useful and detrimental plants [1,2]. With scientific 
advances, novel utilizations of plants emerged and new mysteries of plants’ wonderful world were divulged by 
extensive and comprehensive researches [3,4]. Because of emergence of diseases, human addressed the idea of using 
plants to treat them, which was an introduction to the term medicinal plants in different ethnics and cultures [5]. 
Generally, medicinal plants are very important natural resources which humans have turned to use to relieve pain 
and treat many diseases [6,7]. This utilization has increased with scientific advances, studies on medicinal plants, 
and extraction and identification of their chemical properties and compounds. A variety of compounds with different 
properties were found in plants [8,9]. There has been considerable debate over dangerous side effects of chemical 
drugs in pharmacology and medicine during past 20 years [10,11]. The best way to evade the side effects, both acute 
and long term, has been use of medicinal plants to date [12]. Historically, human has been dependent on medicinal 
plants, and this dependency has not reduced, rather increased, despite today’s extensive and universal scientific and 
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industrial advances [1,2]. Generally, medicinal plant is referred to a plant with known effective substances, which is 
used to treat or prevent disease and has been registered in an international reliable pharmacopoeia. Pharmaceutical 
industries and research teams in many countries have focused their attention to cultivation and production of 
medicinal plants [13]. Iran, a vast country, enjoys extremely favorable conditions for global development of 
knowledge of medicinal plants because of its glorious past in the science of medicinal plants, climate and ecological 
diversity, as well as abundant genetic and species diversity of plants [14,15]. Currently, valuable species of 
medicinal plants are at risk of extinction because of pressures imposed on natural resources, and unfortunately many 
valuable species have gone already extinct. Out of medicinal plants Allium hirtifolium, as one of the most important 
medicinal, industrial and edible plants, grows wild and naturally in highlands [16,17]. Regarding high consumption 
of A. hirtifolium in Iran and likelihood of its extinction as a result of excessive exploitation of its natural habitats, 
research on domestication process and mass production of A. hirtifolium is necessary. Therefore, useful studies on 
cultivation, propagation, and medical uses of A. hirtifolium have been recently conducted to domesticate and 
extensively cultivate this valuable plant in agricultural ecosystems [18]. This article seeks to offer the latest data on 
various aspects of A. hirtifolium. 
 
A review of Alliaceae family highlighting A. hirtifolium 
Alliaceae family is a big family of flowering plants which is significant from gardening and ornamental viewpoints. 
Alliaceae family consists of approximately 250 genuses and 3500 species. Different species of Alliaceae family 
occur most regions of the world (The plants of this family are perennial, herbacious, and are rarely annual). Most 
plants of Alliaceae family have underground stem, corm, and bulb. Perianth parts are separate or continuous and 
mostly petaloid (4,6,8). The seeds are round, triangular or discoid. Overall, most plants of Alliaceae family are 
decoratively and aesthetically worthwhile. The habitats of these plants, such as Fritillaria imperialis, are mainly 
located in Zagros Mountains, western Iran. Hyacinthus spp and Eremurus spp which have been recently 
commercially available, and ledebourii and colohicum spp are some beautiful flowers of Liliaceae family. Mosir, 
garlic, onion, and leek are other commercially available plants of this family, which are approximately publicly 
known [19]. Table 1 shows some plants of Liliaceae family. 
 
Table 1. A list of Liliaceae family plants [20]  
 
Geographical distribution in Iran English 
name 
Persian name Scientific name Row 
Golestan, Mazandaran, Gilan, Azarbaijan, Khuzestan, Hormozgan, Kerman, 
Isfahan, Tehran, Southern Khorasan Onion Piaz-e khoraki Allium cepa L. 1 
This species is grown in Iran. Leek Tareh farangi Allium porrum L. 2 
Golestan, Mazandaran, Gilan, Azarbaijan, Hamadan, Khuzestan, Fars, Isfahan, 
Tehran Garlic Sir Allium sativum L. 3 
West Azarbaijan, Kurdistan, Kermanshah, Hamadan, Lorestan, Isfahan, 
Chaharmahal and Bakhtiari, Kohgiluyeh and Boyer-Ahmad, Fars, Arak, 
Nahavand, Yasouj, Borujerd, Khansar 
Mosir Mosir Allium hirtifolium Boiss 4 
Mazandaran, East Azarbaijan, West Azarbaijan, Kermanshah, Arak, Tehran 
(Karaj) Asparagus Marchoubeh 
Asparagus 
officinalis L. 5 
Different regions except for tropical regions Meadow 
saffron 
Gol-e hasrat-e 
ziba 
Colchicum 
speciosum steven 6 
Gorgan, Bandar-e Gaz, Mazandaran (Tonekabon), Gilan (Bandar-e Anzali), 
Ardabil 
Butcher's 
bromm Kole-Khas 
Ruscus hyrcanus 
woron 
7 
In different regions, oak forests, Fars (Nourabad, Kazeroun), Khuzestan 
(Izeh,Baghmalek) 
Shore sea 
onin Onsol 
Urginea 
maritima 
(L.)Baker 
8 
Kermanshah, Ilam, Isfahan, Arak, Chaharmahal and Bakhtiari, Lorestan, Fars, 
Kohgiluyeh and Boyer-Ahmad 
Crown 
imperial 
Laley-e 
vajgoun 
Fritillaria 
imperialis L. 9 
Gorgan, Mazandaran, Gilan Rough bindweed Azmolk Smilax excels L. 10 
East Azarbaijan, Kurdistan, Kermanshah, Lorestan, Kerman, Tehran Tassel hyacinth Kalaghak Muscari spp. 11 
 
Allium genus consists of approximately 120 species, of which more than 30 occur only in Iran, spreading in 
approximately all regions of Iran from agricultural lands and orchards, sandy desert areas to high mountain peaks, 
except the southern coastal plain. Some of the species are widely known for their therapeutic properties and have 
been also cultivated, and some of them are generally used and eaten in vegetable rice or soup in different regions of 
Iran in early spring while their therapeutic properties are not precisely known. Plants of Allium genus clearly have a 
bulb[20]. Study findings indicate that the plants of Allium genus have antibacterial, antifungal, antiviral, 
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antiprotozoal, and antihelmintic properties [21,22]. The plants of Allium genus are rich in organosulfur compounds 
and flavonoids and exhibit antioxidant and antibacterial properties[23]. They also play a protective role against free 
radicals, which is attributed to allicin existing in most plants of Allium genus[24]. Table 2 classification of Allium 
spp in other among plants. 
 
Tabhe 2: Clasification of Allium Spp 
 
Classification 
Plantae Kingdom 
Magnoliophyta Division 
Monocotyledon Class 
Lilioideae Sub-class 
Liliales Order 
Liliaceae Family 
Allium Genus 
Hirtifolium species 
 
Botanical features of Mosir  
A. hirtifolium Boiss, equivalent to Allium stipitatum Regel, is a bulbous, perennial plant from Liliaceae, which is 
native to Iran and grows in highlands and mountainous regions [25]. Occasionally, A. hirtifolium is mistakenly 
referred to as shallot in English vocabulary. But, shallot is equivalent to Allium ascalonicum L. which has been 
called as Mosir in some references. However, A. ascalonicum does not occur in Iran and Mosir is not a correct 
equivalent for this plant in Persian vocabulary. Clearly speaking, Mosir is the wild, mountainous type of A. 
hirtifolium and hence it is occasionally referred to as sir-e kouhi (mountainous garlic) in Persian. Mosir is slightly 
bitter and may be called as talkh-e piaz (bitter onion), as well. A. hirtifolium has cylindrical and hollow leaves 
reaching 30 cm in length. The flowers are orange and/or purple, and usually unproductive.A. hirtifolium bulbs are 
2.5-4 cm in diameter, with gray outer shell and bare, slightly streaky stems of 80-120 cm in height, 4-5 leaves, with 
a ciliated or rarely trichome-free edge, more or less glabrous or almost trichome-free in basal part. Peduncles are 
3.5-5 cm in length and the perianth is star-like, purple and rarely white. In the first year, A. hirtifolium produces a 
very small bulb, and in the fourth and/or fifth year simultaneously with production of inflorescence, produces a 
daughter bulb, turning into mother bulb in the next year. Therefore exploiting A. hirtifolium bulb by seeding takes a 
long time in order for the bulb to reach the desired size. A. hirtifolium seed has dormancy and should be sown in the 
autumn so that the dormancy period is broken under normal conditions [23,26]. The appropriate temperature for A. 
hirtifolium growth is 6-27°C with pH 4.5-8.3 as the most appropriate for growth.A. hirtifolium flowers are orange or 
purple and usually unproductive. A. hirtifolium bulb has the chromose number 16. The chromosomes are mainly 
metacentric (Out of eight chromosomes, seven are metacentric and one is submetacentric). A. hirtifolium karyotype 
is homogenous as the chromosomes are mainly metacentric rather submetacentric. The bulbs start to grow as the 
weather gets cold, and in autumn the primary roots of bulbs grow initially, while the growth speed of aerial parts 
including leaves increases and then inflorescence is developed depending on bulb's age and weight. June is the end 
of A. hirtifolium lifetime and its bulb enters into summer dormancy [27]. 
B. 
 
 
Figure 1. Allium hirtifolium In Iran 
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A. hirtifolium medicinal and therapeutic features 
Medically, A. hirtifolium is an important medicinal plant whose edible parts are leaves and bulbs. Bulbous plants are 
rich sources of antioxidants and valuable substances such as vitamins A, B, C, and D, beta-carotene, and essential 
amino acids. These plants also contain considerable amounts of potassium, phosphorus, calcium, sodium, 
magnesium, iron, copper, and manganese [28]. A. hirtifolium is also appetizing and contributes to strengthening 
digestive system, and since water comprises over 90% of vegetables weight, A. hirtifolium bulb with 30% dry 
material is a very valuable vegetable for production of dry products such as A. hirtifolium powder. The most 
important fatty acids of A. hirtifolium are linolenic acid, linoleic acid, palmitic acid, palmitoleic acid, stearic acid, 
and oleic acid. A. hirtifolium has a special taste and its dried bulb slices are used as an additive to yogurt and pickles. 
A. hirtifolium powder is used as a delicious additive or condiment for foods in Iran [29,26]. 
 
.A. hirtifolium could cause decrease in the level of high density lipoprotein (HDL) and low density lipoprotein, but it 
has no effect on triglyceride. In a study of  A. hirtifolium  alcoholic  extract  and  male  rats, three - week 
administration of the extract adversely decreased HDL cholesterol, mainly explained by incidence of enzyme  
disorders  in the synthesis of this substance in liver tissue [30]. Studies have demonstrated that use of A. hirtifolium 
decreases the risk of coronary heart diseases. This plant  has caused decrease in glycemia  and hence resistance  to 
insulin [21,31]. A study on healthy and diabetic  mice demonstrated that steroid saponins of  A. hirtifolium caused  
increased appetite and hence weight  gain in healthy and diabetic mice  through affecting circadian  rhythms and  
behaviors related to eating [32]. Many plants of Allium  genus  have a compound  called allicin, a strong antibiotic. 
Antibiotic property of 1 g allicin is equivalent  to 15 units of penicillin. The plant extract  at 500-800 µg/mL could 
inhibit  different steps of angiogenesis, which was attributed to  flavonoids, particularly quercetin, existing in A. 
hirtifolium ethyl acetate extract. Therefore  might be  useful when angiogenesis  is pathologic (tumors, metastasis, 
arthritis) [33,34].  hirtifolium chloroform extract and the allicin extracted from it can partially inhibit the spread of 
tumor cells. Some saponins, which are abundantly found in A. hirtifolium, can reduce synthesis of cholesterol and 
fatty acid in the liver tissue. A. hirtifolium bulb inhibits  cancer cell  proliferation  and is  used for  treatment  of  
rheumatism, superficial wounds, kidney stones, blood pressure, and diarrhea [35,34,36]. Tables 3 and 4 show some 
saponins in A. hirtifolium.A. hirtifolium exerts considerable antioxidant and antibacterial properties because of 
containing flavonoids such as quercetin  and  sulfur  compounds  including  dialyl  disulfide, inhibiting  the oral 
transmission  of  significant  bacteria  including  Listeria  monocytogenes, Staphylococcus aureus, Salmonella and 
Escherichia coli [37,38]. Table 5 shows some antimicrobial properties of A. hirtifolium 
 
Table 3. Spirostane-type sapogenins identified in the Allium hirtifolium[39]  
 
Structure Common name 
(25R)-5α -spirostane-2α ,3 β -diol 
(25R)-5α -dpirostane-2α ,3 β -,5α -triol 
(25R)-5α -spirostane-2α ,3 β  , 5α ,σβ -tetrol 
Gitogenin 
 
Agapanthagenin 
 
Alliogenin 
 
Table 4. Steroidal saponins/sapogenins reported in Allium hirtifolium[39]  
 
Sugar residue sapogenin  Glycoside common 
 
3-O- β -D-Xy1-(1 →3)-O- β -D-Glc- (1 →4)-O- β -D-Gal 
26-O- β -D-Glc-3-O- β -D-Xy1-(1 →3)- O- β -D-Glc-
(1 →4)-O- β -D-Gal 
26-O- β -D-Glc-3-O- β -D-Xy1-(1 →3)- O- β -D-Glc-
(1 →4)-O- β -D-Gal 
26-O- β -D-Glc-3-O- β -D-Xy1-(1 →3)- O- β -D-Glc-
(1 →4)-O- β -D-Gal 
26- β -D-Glc 
26- β -D-Glc 
 
Agigenin 
Furostane-2α ,3 β ,22α -triol 
Furostane-2α ,3 β ,22 β -triol Furos-20(22)-
ene-2α ,3 β ,triol Furostane-2α ,3 β ,22α -
triol Furostane-2α ,3 β ,22α -triol 
 
HIRTIFOLIOSIDE       D 
 
HIRTIFOLIOSIDE       A1 
 
HIRTIFOLIOSIDE       A2 
 
HIRTIFOLIOSIDE        B 
 
HIRTIFOLIOSIDE       C1 
 
HIRTIFOLIOSIDE       C2 
 
Glucose(Glc), Galactose (Gal) ,Xylose(Xyl), Glucose(Glc) 
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Table 5. MIC and MBC (mg/ml or µ g/mL) for antibacterial activity of Allium hirtifolium Boiss  againts particular pathogen 
 
 
A.hirtifolium Collecting place Province Pathogense 
Extract 
Part used MIC MBC  Refrences 
Bulb Ilam - 
MRSA 
MSSA 
S.aureus 
S.epidermidis 
S.pneumonia 
E.coli 
E.colia157:H7 
S.typhimurium 
P.mirabilis 
K.pneumonia 
1/88 
1/88 
1/88 
1/88 
3/75 
7/50 
3/75 
3/75 
7/50 
3/75 
7/50 
7/50 
3/75 
15/00 
15/00 
30/00 
15/00 
7/50 
30/00 
15/00 
Mg/mL 
 
[40] 
Bulb shahrekord Charmehabakh- teyari 
B.subtilis 
E.faecalis 
S.aureus 
E.coli 
K.pneumoniae 
7/5 
15 
15 
15 
0 
- 
- 
- 
- 
- 
Mg/mL 
 
[23] 
Bulb Marghemalek Charmehalba kheyari 
B.subtilis 
E.faecalis 
S.aureus 
E.coli 
K.pneumoniae 
15 
15 
15 
15 
0 
- 
- 
- 
- 
- 
Mg/mL 
 
[23] 
Bulb Sahneh Kermanshah 
B.subtilis 
E.faecalis 
S.aureus 
E.coli 
K.pneumoniae 
7/5 
15 
0 
15 
0 
- 
- 
- 
- 
- 
Mg/mL 
 
[23] 
Bulb Alashtar Lorestan 
B.subtilis 
E.faecalis 
S.aureus 
E.coli 
K.pneumoniae 
15 
15 
15 
15 
0 
- 
- 
- 
- 
- 
Mg/mL 
 
[23] 
Bulb Khorramabad Lorestan 
B.subtilis 
E.faecalis 
S.aureus 
E.coli 
K.pneumoniae 
3/7 
15 
15 
15 
0 
- 
- 
- 
- 
- 
Mg/mL 
 
[23] 
Bulb Divandareh Kurdestan 
B.subtilis 
E.faecalis 
S.aureus 
E.coli 
K.pneumoniae 
7/5 
15 
15 
15 
0 
 
- 
- 
- 
- 
- 
Mg/mL 
 
[23] 
Bulb Asadabad Hamedan 
B.subtilis 
E.faecalis 
S.aureus 
E.coli 
K.pneumoniae 
7/5 
7/5 
15 
7/5 
15 
- 
- 
- 
- 
- 
Mg/mL 
 
[23] 
Bulb Malayer Hamedan 
B.subtilis 
E.faecalis 
S.aureus 
E.coli 
K.pneumoniae 
15 
15 
15 
15 
0 
 
- 
- 
- 
- 
- 
Mg/mL 
 
[23] 
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Bulb Nahavand Hamedan 
B.subtilis 
E.faecalis 
S.aureus 
E.coli 
K.pneumoniae 
15 
15 
15 
15 
0 
- 
- 
- 
- 
- 
Mg/mL 
 
[23] 
Bulb Avej Qazvin 
B.subtilis 
E.faecalis 
S.aureus 
E.coli 
K.pneumoniae 
15 
15 
15 
15 
15 
- 
- 
- 
Mg/mL 
 
[23] 
Bulb Esfahan Esfahan 
B.subtilis 
E.faecalis 
S.aureus 
E.coli 
K.pneumoniae 
1/87 
7/5 
7/5 
7/5 
15 
- 
- 
- 
- 
- 
/mL Mg 
[23] 
Bulb Samsami charmehalbakhteyari 
B.cereus 
L.monocytogenes 
P.vulgaris 
S.typhimurium 
62/5 
125 
125 
125 
- 
- 
- 
- 
/mL gµ [41] 
Bulb Khaki charmehalbakhteyari 
B.cereus 
L.monocytogenes 
P.vulgaris 
S.typhimurium 
125 
250 
125 
125 
- 
- 
- 
- 
/mL gµ [41] 
Bulb Dashte-Laleh charmehalbakhteyari 
B.cereus 
L.monocytogenes 
P.vulgaris 
S.typhimurium 
62/5 
125 
125 
125 
- 
- 
- 
- 
/mL gµ [41] 
Bulb - - 
S.aureus 
S.epidermidis 
E.coli 
K.pneumoniae 
P.mirabilis 
P.aeruginosa 
156-312 
19/5-78 
78-156 
156-312 
156-624 
20-80 
- 
- 
- 
- 
- 
- 
/mL gµ [42] 
 
CONCLUSION 
 
The existence of 11 of 13 globally known climates, 300 sunny days a year, and 40-50°C difference in temperature 
between the coldest and hottest regions in Iran have provided the conditions for utilization of unique ecological 
conditions in a vast country such as Iran [43-45]. In Iran, there are about 500 aromatic and medicinal plant species, 
many of which are exclusively native to Iran. Increasing consumption of medicinal plants as raw materials for the 
production of herbal medicines without development of appropriate methods of planting and management leads to 
destruction of nature. Easy access to habitat of plants, lack of knowledge about the rate and methods of sustainable 
harvesting methods of medicinal plants, the profitable market, and no legal policies are some factors contributing to 
the excessive use of medicinal species and reducing their genetic diversity [46]. Medicinal plants are thought to be at 
less risk than other crops because of growing in their natural habitats. However, some factors including urban 
development in new areas, desertification and increased toxins in the environment are seriously threatening 
ecological balance and ecosystems of these valuable plants and also genetic diversity of many useful wild species. 
Therefore cultivation of these plants should be seriously considered. A. hirtifolium is a medicinal plant which is 
collected from natural habitats In Iran and is variously used by native people and also in traditional medicine [47]. 
However, excessive exploitation of natural areas by local communities has put this medicinal species at risk [48]. 
Therefore, sustainable utilization of A. hirtifolium from natural areas alongside domestication seems necessary to 
preserve A. hirtifolium. In addition, in case of codified planning and adequate monitoring of exploitation of A. 
hirtifolium, its harvesting could be continued. Therefore, some plants that could be cultivated and spread across 
different regions of Iran and are at risk of extinction could be appropriately cultivated in any regions through 
detailed and scientific works. Hence, support measures are recommended to detect, preserve, and proliferate 
medicinally valuable species in different regions of Iran. Most of therapeutic effects of A. hirtifolium has been 
attributed to its antioxidant activity. Antioxidants can scavenge free radicals which can cause a wide variety of 
diseases [49-88]. Therefore, other than mentioned therapeutic effects, A. hirtifolium may be effective in all of these 
oxidative stress induced diseases.   
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